Telus Corporation Ordinary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Telus Corporation Ordinary Shares is far larger — about 7× Vir Biotechnology Inc. Common Stock's market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Telus Corporation Ordinary Shares for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| TU | VIR | |
|---|---|---|
Market Cap | $12.52B | $1.80B |
Volume | 6,655,034 | 1,782,836 |
Sector | Media | Health |
52-Week High | $15.33 | $11.78 |
52-Week Low | $7.72 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $33.57B | $1.36B |
Dividend Yield | 6.59% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →